The Israel Life Science Industry interviewed AGG Partner Alan G. Minsk for a feature story titled, “Get Inside FDA’s Head and Do Your Homework” that was published on the “Global Analysis” section of their website. In the interview, Aviva Mishmari asks Mr. Minsk questions about dealing with the Food and Drug Administration (FDA). Mr. Minsk explains the implications of the new FDA restrictions on a young company pursuing FDA approval and rules of thumb that chief executive officers should follow when negotiating with the FDA to receive a special status. He talks about the best way to use consultation with the FDA before handing them a drug application. As a member of the American-Israel Chamber of Commerce, Mr. Minsk also describes common features and obstacles for Israeli companies who face the FDA regulation process and the best Med-Tech opportunities for Israeli-American cooperation. To read the full article, please click here.